AI-generated summary
The authors report a secondary analysis of a randomized, double-blind, placebo-controlled trial of 49 adults with ADHD and delayed sleep phase syndrome, comparing placebo, melatonin, and melatonin plus bright light therapy. Melatonin with or without bright light therapy did not advance sleep times or improve sleep in general, even though the circadian marker had shifted earlier. The authors conclude that additional behavioral coaching may be needed to shift sleep timing.
- Participants
- 49
- Who or what was studied
- Adults aged 18 to 55 years with attention-deficit/hyperactivity disorder and delayed sleep phase syndrome
- Limits stated in the abstract
- This is an exploratory secondary analysis of a trial, and the abstract does not report effect sizes or statistical details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Attention-deficit/hyperactivity disorder, Bright light therapy, Randomized controlled trial, Placebo-controlled, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.